A Lynn business has received a royal stamp of approval after it won a King’s Award for Enterprise for one of its innovative ...

Tyvaso and Orenitram, leading to [ 11% ] total revenue growth over full year 2024 and surpassing $3 billion in total revenue for the first time in our history. For the fourth quarter, we recorded $790 ...

MannKind’s fair value estimate has been trimmed from US$7.50 to about US$7.17, a modest cut of roughly 4% that signals a slightly more cautious stance in updated models. This shift lines up with ...

I write about sunscreen—a lot. My friends know this. My family knows this. And yet, without fail, every male member of my ...

Rothblatt connected those programs to longer-term scale, stating, "Each of the 2 products will exceed our total revenues of today, a revenue run rate of $3 billion going to $4 billion by the end of ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 11:40 AM EDTCompany ParticipantsMichael Kaseta - COO ...

A major catalyst window opens for this biopharma stock with Q1 earnings due on May 6, and two key FDA decisions in May and ...

For decades, the little blue inhaler was a lifeline for millions of people with asthma. But doctors now know it can make the condition worse - and a quiet revolution in treatment is already ...

East of England companies won 23 of 186 King's Awards for Enterprise announced today – the third highest total by any one ...

Riker Laboratories advertised its new device for treating asthma in 1957—two years after a teenager’s truly inspiring suggestion. Courtesy Mark Sanders In April 1955, 13-year-old Susie Maison asked ...

Asthma and COPD can make every breath feel like a challenge, but the right treatment plan changes everything. From quick-relief inhalers to daily controllers and advanced biologics, knowing your ...